Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

390
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
390
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.5K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.5K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

368
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
368
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

327
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
327
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.6K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K
What is an Experiment?01:12

What is an Experiment?

19.8K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
19.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rate of IPG Placement for Sacral Neuromodulation in Patients With CNS Pathology.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Nonparametric motion control in functional connectivity studies in children with autism spectrum disorder.

Biometrics·2026
Same author

Performance of fecal inflammatory biomarkers to identify watery shigellosis: Findings from the Enterics for Global Health (EFGH) Shigella surveillance study.

PLoS neglected tropical diseases·2026
Same author

Assessing Racial Disparities in Healthcare Expenditures via Mediator Distribution Shifts.

Statistics in medicine·2026
Same author

Analytic Considerations for the Evaluation of Tuberculosis Preventative Therapy Effectiveness Among People Living with HIV.

Observational studies·2026
Same author

Microcosting the optimization of PrEP implementation among sexual and gender minority individuals with a substance use disorder.

Addiction science & clinical practice·2026

Related Experiment Video

Updated: Apr 1, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Target trial emulation without matching: a more efficient approach for evaluating vaccine effectiveness using

Emily Wu1, Elizabeth Rogawski McQuade2, Mats Stensrud3

  • 1Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.

Epidemiology (Cambridge, Mass.)
|March 30, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new method to measure vaccine effectiveness over time, improving precision and clarity compared to traditional matching techniques. The proposed approach offers significant efficiency gains for real-world vaccine studies.

Keywords:
COVID-19Causal inferenceCohort designEstimandsMatchingTarget trial emulationVaccine effectiveness

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Related Experiment Videos

Last Updated: Apr 1, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.3K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Vaccinology

Background:

  • Real-world vaccine effectiveness is often assessed using matching in observational studies, following target trial emulation.
  • Matching methods have limitations in estimand clarity and precision, especially when vaccine uptake and infection dynamics change rapidly over calendar time.

Purpose of the Study:

  • To propose a novel causal estimand for vaccine effectiveness that summarizes effectiveness over calendar time, analogous to randomized controlled trial efficacy.
  • To develop and evaluate simple-to-implement estimators for this new estimand.

Main Methods:

  • Proposed a new causal estimand for vaccine effectiveness over calendar time.
  • Developed estimators based on two hazard regression models.
  • Validated the proposed estimator through simulations and a real-world study of the Pfizer-BioNTech COVID-19 vaccine in children aged 5-11 years.

Main Results:

  • The proposed estimator demonstrated similar scientific inferences compared to matching-based estimators.
  • Significant efficiency gains were observed with the proposed estimator over commonly used matching methods.
  • The estimator was successfully applied to assess Pfizer-BioNTech COVID-19 vaccine effectiveness against SARS-CoV-2 infection in children.

Conclusions:

  • The novel causal estimand and associated estimators provide a more precise and clear measure of vaccine effectiveness in real-world settings.
  • This approach offers substantial efficiency improvements for observational vaccine effectiveness studies.
  • The method is applicable to dynamic epidemiological scenarios and specific vaccine evaluations, such as for pediatric COVID-19 vaccination.